test

Kevin Tang

@Tang Capital Management Llc

Latest period2024 - Q3ReportedManaged Assets$1.4BTotal holdings154
Assets growth rate42.57%Assets growth rate (2-Q avg)22.41%Continuous growth in asset value2 quarters

Portfolio positions

This chart displays the top 10 holdings in Tang Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 154 positions.

Assets under management

The assets under management (AUM) of Tang Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.4B in assets, with a quarterly growth rate of 42.57% and a 2-quarter average growth rate of 22.41%. The portfolio is managed by Kevin Tang, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
AUPHAurinia Pharmaceuticals Inc
Recent Activity
Increased 160.11%
3.79%
$52.992M
7.23M shares@ $7.33 avg price
VRDNViridian Therapeutics Inc
Recent Activity
Increased 61.03%
3.65%
$51.027M
2.243M shares@ $22.76 avg price
KALVKalvista Pharmaceuticals Inc
Recent Activity
Increased 2.44%
3.58%
$50.044M
4.322M shares@ $11.58 avg price
IMCRImmunocore Hldgs Plc
Recent Activity
Increased 172.59%
2.46%
$34.417M
1.106M shares@ $31.13 avg price
APLTApplied Therapeutics Inc
Recent Activity
Increased 17.17%
1.66%
$23.205M
2.73M shares@ $8.5 avg price
GLPGGalapagos Nv
Recent Activity
Increased 1158.79%
1.44%
$20.153M
700,000 shares@ $28.79 avg price
GSKGsk Plc
Recent Activity
Increased 12.5%
1.32%
$18.396M
450,000 shares@ $40.88 avg price
LENZLenz Therapeutics Inc
Recent Activity
Increased 2.59%
1.31%
$18.207M
766,940 shares@ $23.75 avg price
NVDANvidia Corporation
Recent Activity
Increased 28.45%
1.29%
$17.941M
147,732 shares@ $121.44 avg price
KNSAKiniksa Pharmaceuticals Intl
Recent Activity
Increased 0.53%
1.13%
$15.709M
628,609 shares@ $25.0 avg price